Source: International Psychogeriatrics. Unidade: FM
Subjects: DEPRESSÃO, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORLENZA, Orestes V. et al. Antidepressant efficacy and safety of low-dose Sertraline and Standard-Dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial. International Psychogeriatrics, v. 13, n. 1, p. 75-84, 2001Tradução . . Acesso em: 21 maio 2024.APA
Forlenza, O. V., Almeida, O. P., Stoppe Jr., A., Hirata, E. S., & Ferreira, R. C. R. (2001). Antidepressant efficacy and safety of low-dose Sertraline and Standard-Dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial. International Psychogeriatrics, 13( 1), 75-84.NLM
Forlenza OV, Almeida OP, Stoppe Jr. A, Hirata ES, Ferreira RCR. Antidepressant efficacy and safety of low-dose Sertraline and Standard-Dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial. International Psychogeriatrics. 2001 ; 13( 1): 75-84.[citado 2024 maio 21 ]Vancouver
Forlenza OV, Almeida OP, Stoppe Jr. A, Hirata ES, Ferreira RCR. Antidepressant efficacy and safety of low-dose Sertraline and Standard-Dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial. International Psychogeriatrics. 2001 ; 13( 1): 75-84.[citado 2024 maio 21 ]
